» Articles » PMID: 34321997

The Good, the Bad, and the Deadly: Adenosinergic Mechanisms Underlying Sudden Unexpected Death in Epilepsy

Overview
Journal Front Neurosci
Date 2021 Jul 29
PMID 34321997
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Adenosine is an inhibitory modulator of neuronal excitability. Neuronal activity results in increased adenosine release, thereby constraining excessive excitation. The exceptionally high neuronal activity of a seizure results in a surge in extracellular adenosine to concentrations many-fold higher than would be observed under normal conditions. In this review, we discuss the multifarious effects of adenosine signaling in the context of epilepsy, with emphasis on sudden unexpected death in epilepsy (SUDEP). We describe and categorize the beneficial, detrimental, and potentially deadly aspects of adenosine signaling. The good or beneficial characteristics of adenosine signaling in the context of seizures include: (1) its direct effect on seizure termination and the prevention of status epilepticus; (2) the vasodilatory effect of adenosine, potentially counteracting postictal vasoconstriction; (3) its neuroprotective effects under hypoxic conditions; and (4) its disease modifying antiepileptogenic effect. The bad or detrimental effects of adenosine signaling include: (1) its capacity to suppress breathing and contribute to peri-ictal respiratory dysfunction; (2) its contribution to postictal generalized EEG suppression (PGES); (3) the prolonged increase in extracellular adenosine following spreading depolarization waves may contribute to postictal neuronal dysfunction; (4) the excitatory effects of A receptor activation is thought to exacerbate seizures in some instances; and (5) its potential contributions to sleep alterations in epilepsy. Finally, the adverse effects of adenosine signaling may potentiate a deadly outcome in the form of SUDEP by suppressing breathing and arousal in the postictal period. Evidence from animal models suggests that excessive postictal adenosine signaling contributes to the pathophysiology of SUDEP. The goal of this review is to discuss the beneficial, harmful, and potentially deadly roles that adenosine plays in the context of epilepsy and to identify crucial gaps in knowledge where further investigation is necessary. By better understanding adenosine dynamics, we may gain insights into the treatment of epilepsy and the prevention of SUDEP.

Citing Articles

Clinico-genetic Analysis of Adenosine Signaling Pathway in Drug-Resistant Epilepsy.

Dhiman V, Karan K, Satischandra P, Mahadevan A, Arimappamagan A, Bharath R Ann Indian Acad Neurol. 2025; 28(1):49-57.

PMID: 39951024 PMC: 11892979. DOI: 10.4103/aian.aian_358_24.


Pharmacology of Adenosine A Receptor Agonist in a Humanized Esterase Mouse Seizure Model Following Soman Intoxication.

Shih T, Munoz C, Acon-Chen C, Keith Z Neurotox Res. 2024; 42(5):41.

PMID: 39230655 PMC: 11374867. DOI: 10.1007/s12640-024-00717-z.


Disruption of adenosine metabolism increases risk of seizure-induced death despite decreased seizure severity.

Purnell B, Bhasin J, Rust B, George S, Bah K, Lu T Epilepsia. 2024; 65(9):2798-2811.

PMID: 39018000 PMC: 11534556. DOI: 10.1111/epi.18055.


Effect of adenosinergic manipulations on amygdala-kindled seizures in mice: Implications for sudden unexpected death in epilepsy.

Purnell B, Petrucci A, Li R, Buchanan G Epilepsia. 2024; 65(9):2812-2826.

PMID: 38980980 PMC: 11534534. DOI: 10.1111/epi.18059.


Learning and memory function preserved by delayed A adenosine receptor agonist treatment following soman intoxication in rats and a humanized esterase mouse model.

Harkins J, Langston J, Keith Z, Munoz C, Acon-Chen C, Shih T Neuropharmacology. 2024; 253:109983.

PMID: 38704023 PMC: 11132435. DOI: 10.1016/j.neuropharm.2024.109983.


References
1.
Gouder N, Scheurer L, Fritschy J, Boison D . Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J Neurosci. 2004; 24(3):692-701. PMC: 6729249. DOI: 10.1523/JNEUROSCI.4781-03.2004. View

2.
Wall M, Dale N . Activity-dependent release of adenosine: a critical re-evaluation of mechanism. Curr Neuropharmacol. 2009; 6(4):329-37. PMC: 2701281. DOI: 10.2174/157015908787386087. View

3.
Rosen J, Berman R . Prolonged postictal depression in amygdala-kindled rats by the adenosine analog, L-phenylisopropyladenosine. Exp Neurol. 1985; 90(3):549-57. DOI: 10.1016/0014-4886(85)90152-9. View

4.
Johansson B, Halldner L, Dunwiddie T, Masino S, Poelchen W, Gimenez-Llort L . Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc Natl Acad Sci U S A. 2001; 98(16):9407-12. PMC: 55434. DOI: 10.1073/pnas.161292398. View

5.
Bennett D . SLEEP DEPRIVATION AND MAJOR MOTOR CONVULSIONS. Neurology. 1963; 13:953-8. DOI: 10.1212/wnl.13.11.953. View